ZEMPLAR 5MCG/ML 5 AMPS. (NET PRICE)

Therapeutic indications Paricalcitol is indicated in adults for the prevention and treatment of secondary hyperparathyroidism in patients with chronic kidney disease Stage 5 who are undergoing haemodialysis. Paricalcitol is a synthetic biologically active vitamin D analogue of calcitriol with modifications to the side chain (D2) and the A (19-nor) ring. Unlike calcitriol paricalcitol is a selective vitamin D receptor (VDR) activator.